References
- Döhner H, Estey EH, Amadori S, . Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453–474.
- Faderl S, O’Brien S, Pui CH, . Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 2010;116:1165–1176.
- Pautas C, Merabet F, Thomas X, . Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study. J Clin Oncol 2010;28:808–814.
- Van Der Jagt R, Robinson KS, Belch A, . Sequential response-adapted induction and consolidation regimens idarubicin/cytarabine and mitoxantrone/etoposide in adult acute myelogenous leukemia: 10 year follow-up of a study by the Canadian Leukemia Studies Group. Leuk Lymphoma 2006;47:697–706.
- Anderson JE, Kopecky KJ, Willman CL, . Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study. Blood 2002;100:3869–3876.
- Hickman RO, Buckner CD, Clift RA. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871–875.
- Hiemenz J, Skelton J, Pizzo PA. Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis 1986;5:6–11.
- Sekeres MA, Elson P, Kalaycio ME, . Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood 2009;113:28–36.
- McDiarmid S, Hamelin L, Huebsch L. Leading change: evaluation of a nurse-led initiative from Hickman catheters to peripherally inserted central catheters as the vascular access option for autologous stem cell transplant recipients. J Infus Nurs 2006;29:81–88.
- Cortelezzi A, Fracchiolla NS, Maisonneuve P, . Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 2003;44:1495–1501.
- Nosari AM, Nador G, De Gasperi A, . Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients. Leuk Lymphoma 2008;49:2148–2155.
- O’Neill VJ, Jeffrey Evans TR, Preston J, . A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapy. Acta Oncol 1999;38:1103–1107.
- Strahilevitz J, Lossos IS, Verstandig A, . Vascular access via peripherally inserted central venous catheters (PICCs): experience in 40 patients with acute myeloid leukemia at a single institute. Leuk Lymphoma 2001;40:365–371.
- Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 1953;39:368–376.
- Higgs ZC, Macafee DA, Braithwaite BD, . The Seldinger technique: 50 years on. Lancet 2005;366:1407–1409.
- Tran H, Arellano M, Chamsuddin A, . Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma 2010;51:1473–1477.
- Robinson KS, Anderson DR, Gross M, . Ultrasonographic screening before hospital discharge for deep vein thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med 1997;127:439–445.
- Anderson DR, Gross M, Robinson KS, . Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications: the Postarthroplasty Screening Study (PASS). Chest 1998;114:119S–122S.